Anti-life S.959 (FDA Power Grab Bill)

Anti-life S.959 (FDA Power Grab Bill)

Senate Bill 959 is the most anti-life bill headed for passage since 2010. Sponsored by Sen. Harkin, it has passed out of the Senate HELP Committee and is headed for a vote on the Senate floor.

S.959 vastly expands the power of the FDA, and will enable the FDA to shut down nearly all adult stem cell treatments. As many in the pro-life movement realize, the FDA already prohibits and prevents many adult stem cell treatments. The FDA obtained a ruling in federal court in D.C. against the use of adult stem cells by Regenerative Sciences. But FDA jurisdiction still has limits, which have enabled some breakthroughs with adult stem cells.

S.959 would vastly expanding FDA authority over nearly all biological products, except for “human blood and blood components for transfusion.” (end of Section 2(b), p. 4 of S.959) Adult stem cells will not fit into this exemption, which means that the FDA will obtain jurisdiction to shut down adult stem cell treatments if this bill passes.